Use of activated coagulation factor vii for treating thrombolytic therapy-induced major bleedings
CA 2431986 A1 · Owner: Heusel, Gerhard · Inventors: Stassen, Jean Marie; Skamira, Cord; Wienen, Wolfgang
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Major bleedings induced by thrombolytic/fibrinolytic therapy including , intracranial haemorrhages, are treated by adminstering to a subject suffering from such bleedings an effective amount of activated coagulation factor VII (VIIa) or of a functional derivative thereof.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 20, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended December 20, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 20, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.